These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26442590)

  • 21. Attenuation of dopamine transporter activity by alpha-synuclein.
    Wersinger C; Sidhu A
    Neurosci Lett; 2003 Apr; 340(3):189-92. PubMed ID: 12672538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity.
    Moszczynska A; Saleh J; Zhang H; Vukusic B; Lee FJ; Liu F
    J Mol Neurosci; 2007; 32(3):217-27. PubMed ID: 17873367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.
    Mackie P; Lebowitz J; Saadatpour L; Nickoloff E; Gaskill P; Khoshbouei H
    Brain Behav Immun; 2018 May; 70():21-35. PubMed ID: 29551693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons.
    Hong WC; Amara SG
    FASEB J; 2013 Aug; 27(8):2995-3007. PubMed ID: 23612789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.
    Longo F; Mercatelli D; Novello S; Arcuri L; Brugnoli A; Vincenzi F; Russo I; Berti G; Mabrouk OS; Kennedy RT; Shimshek DR; Varani K; Bubacco L; Greggio E; Morari M
    Acta Neuropathol Commun; 2017 Mar; 5(1):22. PubMed ID: 28292328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system.
    Barroso-Chinea P; Cruz-Muros I; Afonso-Oramas D; Castro-Hernández J; Salas-Hernández J; Chtarto A; Luis-Ravelo D; Humbert-Claude M; Tenenbaum L; González-Hernández T
    Neurobiol Dis; 2016 Apr; 88():44-54. PubMed ID: 26777664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T
    Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G protein βγ subunits play a critical role in the actions of amphetamine.
    Mauna JC; Harris SS; Pino JA; Edwards CM; DeChellis-Marks MR; Bassi CD; Garcia-Olivares J; Amara SG; Guajardo FG; Sotomayor-Zarate R; Terminel M; Castañeda E; Vergara M; Baust T; Thiels E; Torres GE
    Transl Psychiatry; 2019 Feb; 9(1):81. PubMed ID: 30745563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action.
    Karam CS; Javitch JA
    Adv Pharmacol; 2018; 82():205-234. PubMed ID: 29413521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism.
    Khoshbouei H; Wang H; Lechleiter JD; Javitch JA; Galli A
    J Biol Chem; 2003 Apr; 278(14):12070-7. PubMed ID: 12556446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro.
    Lehmensiek V; Tan EM; Schwarz J; Storch A
    Neuroreport; 2002 Jul; 13(10):1279-83. PubMed ID: 12151787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.
    Lee FJ; Liu F; Pristupa ZB; Niznik HB
    FASEB J; 2001 Apr; 15(6):916-26. PubMed ID: 11292651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
    Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
    Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
    Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.
    Eriksen J; Jørgensen TN; Gether U
    J Neurochem; 2010 Apr; 113(1):27-41. PubMed ID: 20085610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-quantum-dot tracking reveals altered membrane dynamics of an attention-deficit/hyperactivity-disorder-derived dopamine transporter coding variant.
    Kovtun O; Sakrikar D; Tomlinson ID; Chang JC; Arzeta-Ferrer X; Blakely RD; Rosenthal SJ
    ACS Chem Neurosci; 2015 Apr; 6(4):526-34. PubMed ID: 25747272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol modulation of interactions between psychostimulants and dopamine transporters.
    Chen R
    Adv Pharmacol; 2024; 99():35-59. PubMed ID: 38467486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions.
    Erdozain AM; De Gois S; Bernard V; Gorgievski V; Pietrancosta N; Dumas S; Macedo CE; Vanhoutte P; Ortega JE; Meana JJ; Tzavara ET; Vialou V; Giros B
    Neuropsychopharmacology; 2018 Apr; 43(5):1041-1051. PubMed ID: 28905875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
    Esposito A; Dohm CP; Kermer P; Bähr M; Wouters FS
    Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.